SCHEMBL1324753

SCHEMBL1324753

O=C(C=Cc1ccc(Cl)cc1)NS(=O)(=O)C=Cc1ccc(Cl)cc1.O=S(=O)(C=Cc1ccc(Cl)cc1)NS(=O)(=O)C=Cc1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 3/20 0.53
HDAC1 Q13547 5/20 0.52
HDAC8 Q9BY41 5/20 0.52
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
CYP1A2 P05177 1/20 0.49
HDAC6 Q9UBN7 3/20 0.48
MMP1 P03956 2/20 0.48
MMP2 P08253 2/20 0.48
MMP9 P14780 2/20 0.48
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
GAA P10253 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
EGFR P00533 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1324751 1.00 HDAC2 (0.53) HDAC2HDAC1HDAC8CA12CA1
SCHEMBL1324241 0.95 HDAC2 (0.57) HDAC2HDAC1HDAC8CA12CA1
SCHEMBL1324806 0.95 HDAC2 (0.57) HDAC2HDAC1HDAC8CA12CA1
SCHEMBL1324240 0.95 HDAC2 (0.57) HDAC2HDAC1HDAC8CA12CA1
SCHEMBL1324320 0.95 HDAC2 (0.57) HDAC2HDAC1HDAC8CA12CA1
SCHEMBL1324399 0.85 CYP1A2 (0.46) HDAC2HDAC1HDAC8CYP1A2HDAC6
SCHEMBL1324397 0.85 CYP1A2 (0.46) HDAC2HDAC1HDAC8CYP1A2HDAC6
SCHEMBL1324278 0.85 HDAC1 (0.39) HDAC2HDAC1HDAC8HDAC6MMP1
SCHEMBL1324636 0.85 CA12 (0.49) CA12CA1CA2CA9MMP1
SCHEMBL1324281 0.85 HDAC1 (0.39) HDAC2HDAC1HDAC8HDAC6MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058313-B2 4-((1E)-2-(((E)-2-fluoro-4-cyanostyrylsulfonyl)methylsulfonyl)vinyl)-3-fluoro-benzonitrile; mitogen activated protein kinase inhibitor; cell growth factor receptor antagonist; angiogenesis inhibitor, antiproliferative and anticarcinogenic agent; neurodegenerative diseases Temple University—Of the Commonwealth System of Higher Education (US) 2011-11-15 US claimed